This work has broadened the scientific community's understanding of PD-L1-mediated tumor immune evasion and the clinical significance of PD-L1 on extracellular vesicles, which would help to develop strategies for accurate monitoring of immunotherapy response and to improve treatment efficacy. The gene discussed is CD274; the disease is neoplasm.